Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
NCT07247188
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Sickle Cell Disease
Interventions
BIOLOGICAL:
PCV21
BIOLOGICAL:
20vPCV
Sponsor
Sanofi